The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
Abstract
This year, 2008, marks the 10-year anniversary of the development of the modern tissue microarray (TMA). During the last decade, the use of TMAs has grown steadily and accounts for a small but increasing percentage of all cancer biomarker studies performed. The growing popularity of TMA-based studies attests to their benefits in the discovery and validation of new biomarkers. This review will focus on these benefits, but also on the faults of TMAs and the challenges of TMA studies that have been overcome in the last decade. We will also discuss the role of TMAs in the latest revolution in cancer treatment, the use of targeted drug therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Self-citationThe cost of dichotomising continuous variables
Altman, D. G., & Royston, P. (2006) · BMJ · doi:10.1136/bmj.332.7549.1080 · Cited by 2,688
Dichotomizing continuous predictors in multiple regression: a bad idea
Royston, P., Altman, D. G., & Sauerbrei, W. (2006) · Statistics in Medicine · doi:10.1002/sim.2331 · Cited by 2,312
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Validation of Tissue Microarray Technology in Breast Carcinoma
Camp, R. L., Charette, L. A., & Rimm, D. L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780204 · Cited by 799
Self-citationTissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints
Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Köchli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63075-1 · Cited by 566
Maximally Selected Chi Square Statistics
Miller, R., & Siegmund, D. (1982) · Biometrics · doi:10.2307/2529881 · Cited by 490
McCabe, A., Dolled-Filhart, M., Camp, R. L., & Rimm, D. L. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji427 · Cited by 292
Self-citationTissue microarray: a new technology for amplification of tissue resources.
Rimm, D. L., Camp, R. L., Charette, L. A., Costa, J. C., Olsen, D. A., & Reiss, M. (2001) · PubMed · Cited by 242
Self-citationCheang, M. C. U., Treaba, D. O., Speers, C. H., Olivotto, I. A., Bajdik, C. D., Chia, S. K., Goldstein, L. C., Gelmon, K. A., Huntsman, D., Gilks, C. B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4155 · Cited by 206
Makretsov, N. A., Huntsman, D. G., Nielsen, T. O., Yorida, E., Peacock, M., Cheang, M. C. U., Dunn, S. E., Hayes, M., van de Rijn, M., Bajdik, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0429 · Cited by 202
Camp, R. L., Dolled-Filhart, M. P., King, B. L., & Rimm, D. L. (2003) · PubMed · Cited by 198
Self-citationShi, T., Seligson, D., Belldegrun, A. S., Palotie, A., & Horvath, S. (2005) · Modern Pathology · doi:10.1038/modpathol.3800322 · Cited by 181
Dolled-Filhart, M., McCabe, A., Giltnane, J., Cregger, M., Camp, R. L., & Rimm, D. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0100 · Cited by 180
Self-citationTechnology Insight: identification of biomarkers with tissue microarray technology
Giltnane, J. M., & Rimm, D. L. (2004) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0046 · Cited by 161
Self-citationRubin, M. A., Zerkowski, M. P., Camp, R. L., Kuefer, R., Hofer, M. D., Chinnaiyan, A. M., & Rimm, D. L. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63171-9 · Cited by 145
Self-citationRimm, D. L. (2006) · Nature Biotechnology · doi:10.1038/nbt0806-914 · Cited by 141
Self-citationWhy do so many prognostic factors fail to pan out?
Hilsenbeck, S. G., Clark, G. M., & McGuire, W. L. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840833 · Cited by 138
Loss of Antigenicity in Stored Sections of Breast Cancer Tissue Microarrays
Fergenbaum, J., García‐Closas, M., Hewitt, S. M., Lissowska, J., Sakoda, L. C., & Sherman, M. E. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.667.13.4 · Cited by 136
Quantitative analysis of estrogen receptor heterogeneity in breast cancer
Chung, G. G., Zerkowski, M. P., Ghosh, S., Camp, R. L., & Rimm, D. L. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700543 · Cited by 115
Self-citationManley, S., Mucci, N. R., Marzo, A. M. D., & Rubin, M. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61759-2 · Cited by 108
Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays
Dolled-Filhart, M. P., Rydén, L., Cregger, M. A., Jirström, K., Harigopal, M., Camp, R. L., & Rimm, D. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1383 · Cited by 108
Self-citationFAITH, D. A., Isaacs, W. B., Morgan, J., et al. (2004) · The Prostate · doi:10.1002/pros.20095 · Cited by 99
Analysis of Protein Expression in Cell Microarrays: A Tool for Antibody-based Proteomics
Andersson, A., Strömberg, S., Bäckvall, H., Kampf, C., Uhlén, M., Wester, K., & Pontén, F. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7001.2006 · Cited by 81
Andersen, C. L., Monni, O. M., Wagner, U., Kononen, J., Barlund, M. T., Bucher, C., Haas, P., Nocito, A., Bissig, H., Sauter, G., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64158-2 · Cited by 73
A human protein atlas based on antibody proteomics.
Persson, A. B., Hober, S., & Uhlén, M. (2006) · PubMed · Cited by 70
Iakovlev, V. V., Pintilie, M., Morrison, A. J., Fyles, A., Hill, R. P., & Hedley, D. W. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700680 · Cited by 63
Pozner-Moulis, S., Cregger, M. A., Camp, R. L., & Rimm, D. L. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700515 · Cited by 61
Self-citationEvaluating technologies for classification and prediction in medicine
Pepe, M. S. (2005) · Statistics in Medicine · doi:10.1002/sim.2431 · Cited by 60
A Prototype for Unsupervised Analysis of Tissue Microarrays for Cancer Research and Diagnostics
Chen, W., Reiss, M., & Foran, D. J. (2004) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2004.828891 · Cited by 54
Bova, G. S., Parmigiani, G., Epstein, J. I., Wheeler, T. M., Mucci, N. R., & Rubin, M. A. (2001) · Human Pathology · doi:10.1053/hupa.2001.23517 · Cited by 53
Schubert, E. L., Hsu, L., Cousens, L. A., Glogovac, J. K., Self, S. G., Reid, B. J., Rabinovitch, P. S., & Porter, P. L. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64351-9 · Cited by 36
Jensen, K. C., Turbin, D. A., Leung, S. C. Y., Miller, M. A., JOHNSON, K., Norris, B. D., Hastie, T. J., McKinney, S. E., Nielsen, T. O., Huntsman, D. D., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9887-y · Cited by 34
Vani, K., Sompuram, S. R., Fitzgibbons, P. L., & Bogen, S. A. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-132-211-nhptru · Cited by 34
Siddiqui, S., Pawelek, J. M., Handerson, T., Lin, C., Dickson, R. B., Rimm, D. L., & Camp, R. L. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0464 · Cited by 33
Self-citation
Cited by
Ki67 in breast cancer: prognostic and predictive potential
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70262-1 · Cited by 1,207
Ki67 is a promising molecular target in the diagnosis of cancer (Review)
LI, L. T., JIANG, G., CHEN, Q., & ZHENG, J. N. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2914 · Cited by 859
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
Self-citationRizzardi, A. E., Johnson, A. T., Vogel, R. I., Pambuccian, S. E., Henriksen, J., Skubitz, A. P., Metzger, G. J., & Schmechel, S. C. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-42 · Cited by 435
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Maibach, F., Sadozai, H., Seyed Jafari, S. M., Hunger, R. E., & Schenk, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02105 · Cited by 312
Metadata
- Authors
- Camp, R. L., Neumeister, V., & Rimm, D. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-12-01
- Volume
- 26
- Issue
- 34
- Pages
- 5630-5637
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2114965121
- Cited by
- 275
- References
- 37
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.